Skip to main content
. 2023 Oct 11;3(10):2074–2081. doi: 10.1158/2767-9764.CRC-23-0084

FIGURE 1.

FIGURE 1

OS by KRAS and treatment arm. A, OS in non-variant patients by radiation level; B, OS in non-variant patients by cetuximab; C, OS in KRAS-variant patients by radiation level; D, OS within KRAS-variant patients by cetuximab. Radiation level P values stratified by cetuximab; cetuximab P values stratified by radiation level.